Loading…

Loading grant details…

Active HORIZON European Commission

Novel N-heterocyclic carbene Gold-Selenium complexes: Green Synthesis and Anticancer Activity


Funder European Commission
Recipient Organization Universiteit Gent
Country Belgium
Start Date Jul 01, 2025
End Date Jun 30, 2027
Duration 729 days
Number of Grantees 1
Roles Coordinator
Data Source European Commission
Grant ID 101210683
Grant Description

This project aims to design new anticancer drugs by using N-heterocyclic carbenes (NHC), gold (Au), and selenium (Se), which have not been explored before. NHCs are chosen as key ligands in homogeneous catalysis with transition metals. Gold compounds, like auranofin, disrupt tumor growth by inhibiting key enzymes.

Se triggers cancer cell death by inducing oxidative stress and blocking sulfur-based cell components.

Cancer poses a global threat, causing millions of deaths and huge economic losses, while available chemotherapy often leads to severe side effects and drug resistance. Therefore, there is a need for more effective and less toxic drugs.

I synthesized and tested several drug candidates in in vitro cancer models, showing selective anticancer activity superior to cisplatin.The project uses a ""weak base route"" to synthesize these new compounds, following green chemistry principles to reduce the ecological impact of chemical synthesis.

The proposed synthetic strategy uses non-toxic solvents and energy-saving protocols to promote sustainable drug development.Cell-free and cell-based assays will assess cytotoxicity, efficacy, and selectivity towards the TrxR1 enzyme, which is critical to cancer growth.

Molecular docking will confirm the inhibition of the biological target, allowing structure-activity relationship (SAR) analysis to optimize drug structure.

By refining the NHC ligand, Au-Se linker, and low core scaffold, the project aims to develop highly effective, targeted anticancer drugs.This research seeks to advance cancer treatment by creating targeted drugs that reduce side effects and improve patient outcomes. Additionally, it aligns with the EU's sustainability goals, promoting environmentally responsible drug development.

The project also strengthens European cooperation in cancer research, both in academia and industry, and will inspire future chemists, with broader economic benefits through innovation in healthcare.

All Grantees

Universiteit Gent

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant